Matarin Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-8,133	Closed	-$231K	–	307
2018 Q1	$231K	Sell	8,133 -1,743	-18%	-$49.6K	0.02%	283
2017 Q4	$208K	Buy	+9,876	New	+$208K	0.02%	284